234 related articles for article (PubMed ID: 32291134)
1. A non-aggregated silicon(IV) phthalocyanine-lactose conjugate for photodynamic therapy.
Li D; Hu QY; Wang XZ; Li X; Hu JQ; Zheng BY; Ke MR; Huang JD
Bioorg Med Chem Lett; 2020 Jun; 30(12):127164. PubMed ID: 32291134
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and photodynamic activities of integrin-targeting silicon(IV) phthalocyanine-cRGD conjugates.
Zheng BY; Yang XQ; Zhao Y; Zheng QF; Ke MR; Lin T; Chen RX; Ho KKK; Kumar N; Huang JD
Eur J Med Chem; 2018 Jul; 155():24-33. PubMed ID: 29852329
[TBL] [Abstract][Full Text] [Related]
3. Porphyrin and phthalocyanine photosensitizers designed for targeted photodynamic therapy of colorectal cancer.
Janas K; Boniewska-Bernacka E; Dyrda G; Słota R
Bioorg Med Chem; 2021 Jan; 30():115926. PubMed ID: 33341498
[TBL] [Abstract][Full Text] [Related]
4. Phthalocyanine-Conjugated Upconversion NaYF
Kostiv U; Patsula V; Noculak A; Podhorodecki A; Větvička D; Poučková P; Sedláková Z; Horák D
ChemMedChem; 2017 Dec; 12(24):2066-2073. PubMed ID: 29105372
[TBL] [Abstract][Full Text] [Related]
5. The first silicon(IV) phthalocyanine-nucleoside conjugates with high photodynamic activity.
Shen XM; Zheng BY; Huang XR; Wang L; Huang JD
Dalton Trans; 2013 Aug; 42(29):10398-403. PubMed ID: 23774802
[TBL] [Abstract][Full Text] [Related]
6. cis-Silicon phthalocyanine conformation endows J-aggregated nanosphere with unique near-infrared absorbance and fluorescence enhancement: a tumor sensitive phototheranostic agent with deep tissue penetrating ability.
Pan J; Ouyang A; Fang W; Cheng G; Liu W; Wang F; Zhao D; Le K; Jiang J
J Mater Chem B; 2020 Apr; 8(14):2895-2908. PubMed ID: 32195527
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of axially disubstituted quaternized silicon phthalocyanines as a promising photosensitizer for the photodynamic treatment of HCT-116, A549 and SH-SY5Y cancer cell lines.
Özgür Yalçın C; Baş H; Barut B; Özel A; Biyiklioglu Z
Dalton Trans; 2020 Apr; 49(15):4927-4934. PubMed ID: 32232308
[TBL] [Abstract][Full Text] [Related]
8. Axially substituted silicon(IV) phthalocyanine and its quaternized derivative as photosensitizers towards tumor cells and bacterial pathogens.
Ömeroğlu İ; Kaya EN; Göksel M; Kussovski V; Mantareva V; Durmuş M
Bioorg Med Chem; 2017 Oct; 25(20):5415-5422. PubMed ID: 28807573
[TBL] [Abstract][Full Text] [Related]
9. A non-aggregated zinc(II) phthalocyanine with hexadeca cations for antitumor and antibacterial photodynamic therapies.
Zheng BD; Li SL; Huang ZL; Zhang L; Liu H; Zheng BY; Ke MR; Huang JD
J Photochem Photobiol B; 2020 Dec; 213():112086. PubMed ID: 33232881
[TBL] [Abstract][Full Text] [Related]
10. A zinc(II) phthalocyanine conjugated with an oxaliplatin derivative for dual chemo- and photodynamic therapy.
Lau JT; Lo PC; Fong WP; Ng DK
J Med Chem; 2012 Jun; 55(11):5446-54. PubMed ID: 22646131
[TBL] [Abstract][Full Text] [Related]
11. Preparation and photodynamic activities of silicon(IV) phthalocyanines substituted with permethylated β-cyclodextrins.
Lau JT; Lo PC; Fong WP; Ng DK
Chemistry; 2011 Jun; 17(27):7569-77. PubMed ID: 21598326
[TBL] [Abstract][Full Text] [Related]
12. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion.
Wei G; Huang L; Jiang Y; Shen Y; Huang Z; Huang Y; Sun X; Zhao C
Eur J Med Chem; 2019 May; 169():53-64. PubMed ID: 30856406
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of peptide-conjugated phthalocyanine photosensitizers with highly hydrophilic modifications.
Li F; Liu Q; Liang Z; Wang J; Pang M; Huang W; Wu W; Hong Z
Org Biomol Chem; 2016 Apr; 14(13):3409-22. PubMed ID: 26956169
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the tumor cell selectivity of a rhodamine-decorated iridium(III) complex by conjugating with indomethacin for COX-2 targeted photodynamic therapy.
Liu C; Xiang J; Xiang C; Li H
Bioorg Chem; 2021 Sep; 114():105142. PubMed ID: 34243072
[TBL] [Abstract][Full Text] [Related]
15. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
16. Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.
Xu P; Chen J; Chen Z; Zhou S; Hu P; Chen X; Huang M
PLoS One; 2012; 7(5):e37051. PubMed ID: 22693566
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial and anticancer photodynamic activity of a phthalocyanine photosensitizer with N-methyl morpholiniumethoxy substituents in non-peripheral positions.
Dlugaszewska J; Szczolko W; Koczorowski T; Skupin-Mrugalska P; Teubert A; Konopka K; Kucinska M; Murias M; Düzgüneş N; Mielcarek J; Goslinski T
J Inorg Biochem; 2017 Jul; 172():67-79. PubMed ID: 28433834
[TBL] [Abstract][Full Text] [Related]
18. Phthalocyanine-polyamine conjugates as pH-controlled photosensitizers for photodynamic therapy.
Jiang XJ; Lo PC; Tsang YM; Yeung SL; Fong WP; Ng DK
Chemistry; 2010 Apr; 16(16):4777-83. PubMed ID: 20309976
[TBL] [Abstract][Full Text] [Related]
19. MnO
Wang X; Dai J; Wang X; Hu Q; Huang K; Zhao Z; Lou X; Xia F
Talanta; 2019 Sep; 202():591-599. PubMed ID: 31171226
[TBL] [Abstract][Full Text] [Related]
20. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
